tiprankstipranks
Trending News
More News >
Veracyte (VCYT)
NASDAQ:VCYT

Compare Veracyte (VCYT) vs. Competitors

Compare
564 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Veracyte
$36.10
$2.85B
95.08
-17.49%
4 Buy
1 Hold
1 Sell
Moderate Buy
Travere Therapeutics
$31.68
$2.83B
-29.21
50.14%
11 Buy
1 Hold
0 Sell
Strong Buy
Celcuity
$107.59
$4.98B
-29.30
760.03%
8 Buy
1 Hold
0 Sell
Strong Buy
Immunovant
$25.15
$5.07B
20.28%
7 Buy
2 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$26.08
$3.19B
-73.57
99.08%
7 Buy
0 Hold
0 Sell
Strong Buy
Disc Medicine
$81.65
$3.08B
-15.24
50.31%
12 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VCYT
Veracyte
36.10
-7.40
-17.01%
TVTX
Travere Therapeutics
31.68
9.82
44.92%
CELC
Celcuity
107.59
95.00
754.57%
IMVT
Immunovant
25.15
4.79
23.53%
ARQT
Arcutis Biotherapeutics
26.08
13.66
109.98%
IRON
Disc Medicine
81.65
25.36
45.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts